ArticleTobacco induced diseases2026
Maternal smoking during pregnancy in relation to adolescent anxiety and poor mental health: A cross-sectional study based on NHANES 2007-2012.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMaternal smoking during pregnancy (MSDP) has been suggested as a potential contributor to adolescent mental health problems, yet existing evidence remains inconsistent. This study aimed to examine the association between MSDP and anxiety and poor mental health outcomes among US adolescents.
methodsThis is a secondary analysis of pooled cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) 2007-2012, which employs a complex, multistage probability sampling design to ensure national representativeness. A total of 1445 adolescents aged 12-15 years were included. MSDP was assessed via parental report. Anxiety and poor mental health symptoms were measured by self-reported numbers of days feeling anxious or mentally unwell in the past 30 days. Weighted negative binomial regression and logistic regression models were used to estimate the rate ratio (RR) and odds ratio (OR), accounting for the complex survey design. Sensitivity analyses were performed using unweighted logistic regression models.
resultsOf the participants, 14.9% were exposed to MSDP. The prevalence of high anxiety (23.2% vs 12.4%, p=0.002) and poor mental health (28.2% vs 12.3%, p=0.001) was greater in the MSDP-exposed group than in the unexposed group. After full adjustment, MSDP was associated with a 1.68-fold increase in the number of anxiety days (95% CI: 1.19-2.37) and a 1.97-fold increase in the number of poor mental health days (95% CI: 1.40-2.77). As categorical outcomes, MSDP was also associated with higher odds of severe anxiety (adjusted odds ratio, AOR=3.03; 95% CI: 1.45-6.29) and severe poor mental health (AOR=3.11; 95% CI: 1.55-6.24). Sensitivity analyses confirmed the robustness of these associations.
conclusionsIn this cross-sectional study, MSDP was associated with a higher likelihood of anxiety and poor mental health in adolescents. Given the study design, causality cannot be established. Future longitudinal studies are warranted to confirm these findings and explore potential underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.